Emergent BioSolutions Inc (NYSE:EBS)
| 21.43 BATS BZX Real-Time Price As of 9:46am ET |  +0.36 / +1.71%Today’s Change | 20.06 Today|||52-Week Range 55.21 | -50.70% Year-to-Date |
Institutional investors purchased a net $126.4 thousand shares of EBS during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 84.25% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Mutual fund holders | 51.56% |
| Other institutional | 32.69% |
| Individual stakeholders | 24.96% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 8/31/2022 | NLB SKLADI, D.O.O. Bought 1.1 Thousand shares of Emergent BioSolutions Inc |
| 8/31/2022 | AMERICAFIRST CAPITAL MANAGEMENT ... Sold 173.00 shares of Emergent BioSolutions Inc |
| 7/29/2022 | NORDEA INVESTMENT MANAGEMENT AB Sold 338.00 shares of Emergent BioSolutions Inc |
Top 10 Owners of Emergent BioSolutions Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| BlackRock Fund Advisors | 15.31% | 7,635,549 | 183,405,887 | -180,744 | -2.31% |
| The Vanguard Group, Inc. | 10.04% | 5,003,924 | 120,194,254 | -67,674 | -1.33% |
| SSgA Funds Management, Inc. | 8.32% | 4,150,632 | 99,698,181 | +681,162 | +19.63% |
| Dimensional Fund Advisors LP | 3.91% | 1,947,332 | 46,774,915 | +578,671 | +42.28% |
| EARNEST Partners LLC | 3.70% | 1,844,621 | 44,307,796 | -226,755 | -10.95% |
| Jacobs Levy Equity Management, In... | 2.18% | 1,085,874 | 26,082,693 | +582,586 | +115.76% |
| D. E. Shaw & Co. LP | 2.14% | 1,065,947 | 25,604,047 | -97,639 | -8.39% |
| Geode Capital Management LLC | 1.67% | 831,951 | 19,983,463 | +14,304 | +1.75% |
| Invesco Capital Management LLC | 1.62% | 808,947 | 19,430,907 | +88,567 | +12.29% |
| Neuberger Berman Investment Advis... | 1.30% | 650,101 | 15,615,426 | +7,070 | +1.10% |
Top 10 Mutual Funds Holding Emergent BioSolutions Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| iShares Core S&P Small Cap ETF | 6.64% | 3,309,190 | 79,486,744 | -10,774 | -0.32% |
| SPDR S&P Biotech ETF | 4.74% | 2,363,893 | 56,780,710 | +35,370 | +1.52% |
| Vanguard Total Stock Market Index... | 2.69% | 1,339,308 | 32,170,178 | +4,848 | +0.36% |
| Vanguard Small Cap Index Fund | 2.30% | 1,147,547 | 27,564,079 | +2,356 | +0.21% |
| iShares Russell 2000 ETF | 2.24% | 1,118,515 | 26,866,730 | +5,983 | +0.54% |
| iShares S&P Small Cap 600 Value E... | 1.30% | 648,251 | 15,570,989 | -2,192 | -0.34% |
| Vanguard Extended Market Index Fu... | 1.19% | 593,551 | 14,257,095 | +738 | +0.12% |
| Harbor Small Cap Value Fund | 1.09% | 543,741 | 13,060,659 | -19,344 | -3.44% |
| iShares Russell 2000 Value ETF | 1.03% | 512,051 | 12,299,465 | +306 | +0.06% |
| DFA US Small Cap Value Portfolio | 0.91% | 451,810 | 10,852,476 | +270,109 | +148.66% |